Profile data is unavailable for this security.
About the company
Xlife Sciences AG is a Switzerland-based biotechnology company. The Company focuses on investing in technologies in the life science industry. It supports researchers and entrepreneurs in positioning, structuring, developing and implementing their concepts. The Company offers its investors direct access to the further development of technologies at a very early stage. The Company cooperates with industrial partners and universities.
- Revenue in CHF (TTM)990.28k
- Net income in CHF21.24m
- Incorporated2013
- Employees17.00
- LocationXlife Sciences AGTalacker 35ZUERICH 8001SwitzerlandCHE
- Phone+41 443858460
- Websitehttps://www.xlifesciences.ch/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adocia SA | 487.59k | -19.31m | 120.15m | 79.00 | -- | -- | -- | 246.42 | -1.53 | -1.53 | 0.0382 | -0.5123 | 0.0234 | 1.15 | 3.15 | 6,705.13 | -92.78 | -43.08 | -- | -72.93 | 32.50 | -- | -3,960.99 | -514.53 | 0.8927 | -2.79 | 2.38 | -- | -81.22 | -46.13 | -206.65 | -- | -27.60 | -- |
| Darwin AG | -93.23bn | -93.23bn | 125.03m | 235.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -91.36 | -- | -99.91 | -- | -- | -- |
| Newron Pharmaceuticals SpA | 6.50m | -17.55m | 135.80m | 23.00 | -- | -- | -- | 20.91 | -0.9641 | -0.9641 | 0.3568 | -1.51 | 0.247 | -- | 3.46 | 282,403.90 | -66.74 | -37.10 | -109.83 | -43.98 | 93.37 | 91.72 | -270.17 | -270.48 | -- | -3.53 | 2.71 | -- | 48.62 | 17.61 | 7.25 | -- | -22.76 | -- |
| Idorsia Ltd | 74.12m | -296.43m | 136.79m | 938.00 | -- | -- | -- | 1.85 | -1.68 | -1.68 | 0.3831 | -5.98 | 0.1271 | 0.236 | 56.93 | 79,021.32 | -50.85 | -46.72 | -123.79 | -53.84 | 77.71 | -- | -399.92 | -709.80 | 0.4153 | -21.55 | 206.68 | -- | 56.93 | 20.25 | 64.01 | -- | -8.01 | -- |
| Vicore Pharma Holding AB | 8.36m | -15.75m | 146.15m | 29.00 | -- | 2.30 | -- | 17.48 | -1.72 | -1.72 | 0.9135 | 3.38 | 0.2045 | -- | 43.73 | 4,343,459.00 | -38.54 | -58.65 | -41.49 | -65.58 | -- | -- | -188.45 | -- | -- | -- | 0.00 | -- | -- | -- | -7.81 | -- | -- | -- |
| Xlife Sciences AG | 990.28k | 21.24m | 153.31m | 17.00 | 11.21 | 0.5582 | 4.84 | 154.81 | 2.38 | 2.38 | 0.1215 | 47.84 | 0.002 | -- | 0.2013 | 58,251.77 | 3.17 | -- | 3.98 | -- | 54.46 | -- | 1,579.69 | -- | -- | -- | 0.1313 | -- | -3.85 | -- | 3.96 | -- | -- | -- |
| Scancell Holdings Plc | 0.00 | -6.55m | 155.98m | 61.00 | -- | -- | -- | -- | -0.0068 | -0.0068 | 0.00 | -0.0038 | 0.00 | -- | -- | 0.00 | -23.24 | -31.66 | -32.48 | -37.66 | -- | -- | -- | -822.37 | -- | -- | 1.21 | -- | -100.00 | -- | 50.91 | -- | 131.54 | -- |
| Egetis Therapeutics AB (publ) | 6.35m | -23.72m | 156.42m | 33.00 | -- | 4.99 | -- | 24.63 | -1.07 | -1.07 | 0.2882 | 1.09 | 0.1425 | 23.00 | 3.61 | 2,933,333.00 | -48.67 | -33.02 | -61.23 | -36.46 | 85.48 | -- | -341.54 | -357.72 | 0.9808 | -19.71 | 0.2605 | -- | 154.87 | 15.35 | -68.68 | -- | -- | -- |
| Nanobiotix SA | 33.77m | -31.21m | 157.23m | 102.00 | -- | -- | -- | 4.66 | -0.763 | -0.763 | 0.8429 | -0.4594 | 0.57 | -- | 17.20 | 355,107.80 | -52.68 | -54.11 | -323.15 | -80.68 | -- | -- | -92.42 | -756.15 | -- | -2.42 | 1.87 | -- | -- | 203.88 | 30.40 | -- | -7.81 | -- |
| Hansa Biopharma AB | 15.19m | -52.50m | 166.40m | 135.00 | -- | -- | -- | 10.96 | -11.34 | -11.34 | 3.21 | -4.72 | 0.1794 | 34.61 | 1.25 | 1,127,321.00 | -62.01 | -47.96 | -86.68 | -56.12 | 53.43 | 64.18 | -345.73 | -835.04 | 2.44 | -41.44 | 1.50 | -- | -13.22 | 109.06 | -36.09 | -- | -35.24 | -- |
| hVIVO PLC | 72.02m | 19.51m | 168.20m | 274.00 | 8.76 | 3.91 | 7.28 | 2.34 | 0.0252 | 0.0252 | 0.0932 | 0.0565 | 0.9242 | -- | 4.25 | 234,974.50 | 25.04 | -0.643 | 46.68 | -1.29 | -- | -- | 27.10 | -0.765 | 1.60 | -- | 0.2530 | -- | 15.61 | 35.40 | 2,176.68 | -- | 136.55 | -- |
| Faron Pharmaceuticals Oy | 0.00 | -29.47m | 172.22m | 34.00 | -- | 133.95 | -- | -- | -0.3166 | -0.3166 | 0.00 | 0.011 | 0.00 | -- | -- | 0.00 | -130.90 | -213.06 | -443.92 | -963.12 | -- | -- | -- | -- | -- | -5.99 | 0.9022 | -- | -- | -- | -7.71 | -- | -16.05 | -- |
| Ose Immunotherapeutics SA | 77.79m | 42.92m | 175.95m | 52.00 | 3.81 | 2.31 | 3.82 | 2.26 | 2.27 | 2.27 | 4.10 | 3.74 | 0.7541 | -- | 32.09 | 1,517,127.00 | 41.60 | -17.17 | 49.66 | -20.55 | -- | -- | 55.17 | -94.71 | -- | 9.24 | 0.3502 | -- | -87.83 | -38.07 | -29.52 | -- | -17.11 | -- |
| Devyser Diagnostics AB | 15.88m | -5.73m | 176.07m | 119.00 | -- | 6.28 | -- | 11.09 | -4.37 | -4.37 | 12.12 | 21.17 | 0.4019 | 1.97 | 5.29 | 1,677,966.00 | -14.51 | -8.97 | -16.40 | -10.15 | 80.00 | 80.14 | -36.11 | -23.91 | 3.81 | -- | 0.1492 | -- | 33.71 | 28.59 | -16.64 | -- | 44.59 | -- |
| Avacta Group Plc | 25.30m | -28.96m | 182.81m | 154.00 | -- | 3.32 | -- | 7.22 | -0.0867 | -0.0867 | 0.075 | 0.1334 | 0.2555 | 4.63 | 3.15 | 146,876.60 | -29.24 | -- | -61.16 | -- | 42.08 | -- | -114.45 | -- | 1.21 | -1.23 | 0.3875 | -- | 140.83 | -- | 32.54 | -- | -- | -- |
| 4Basebio PLC | 666.71k | -11.01m | 186.30m | -- | -- | -- | -- | 279.43 | -0.7843 | -0.7843 | 0.0476 | -0.4075 | 0.0508 | 0.6453 | 10.64 | -- | -83.78 | -- | -97.43 | -- | 69.63 | -- | -1,650.67 | -- | 2.53 | -18.44 | 1.51 | -- | 88.81 | -- | -48.83 | -- | -- | -- |
Data as of Nov 21 2024. Currency figures normalised to Xlife Sciences AG's reporting currency: Swiss Franc CHF
1.94%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| UBS Asset Management Switzerland AGas of 05 Nov 2024 | 61.09k | 1.06% |
| Z�rcher Kantonalbank (Investment Management)as of 30 Aug 2024 | 21.86k | 0.38% |
| CATAM Asset Management AGas of 31 Mar 2021 | 8.00k | 0.14% |
| Pictet Asset Management SAas of 30 Jun 2024 | 5.97k | 0.10% |
| BlackRock Asset Management Deutschland AGas of 07 Nov 2024 | 5.36k | 0.09% |
| Credit Suisse AGas of 30 Sep 2024 | 3.41k | 0.06% |
| Gutmann Finanz Strategien AGas of 30 Sep 2024 | 2.05k | 0.04% |
| Lombard Odier Asset Management (Switzerland) SAas of 30 Sep 2024 | 1.37k | 0.02% |
| DWS CH AGas of 30 Sep 2024 | 1.04k | 0.02% |
| Carne Global Fund Managers (Schweiz) AGas of 31 Oct 2024 | 1.03k | 0.02% |
More ▼
Data from 30 Sep 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
